87 research outputs found

    Policies for African seed enterprise development

    Get PDF
    The commercial seed sector has been slow to develop in sub-Saharan Africa. The paper examines the major impediments and identifies areas in which seed policies can be strengthened. Seed enterprise development has been hampered by regulatory frameworks that favor parastatal enterprises and that inhibit commercial innovation. In addition, government and donor projects provide large amounts of free or subsidized seed that further discourages seed enterprise development. In addition to regulatory reform and the curtailment of many seed distribution projects, there are other policy changes that need to be implemented. National agricultural research institutes need to invest more resources in promoting their varieties and helping to stimulate commercial seed production. Greater emphasis is required on regional strategies for public plant breeding and private seed marketing. National policies need to strengthen input marketing capacity and infrastructure. Finally, donors, governments and NGOs should shift from trying to encourage village-level commercial seed production and instead strengthen farmers’ capacities to assess new varieties and to be effective consumers of commercial input

    The role of informal seed systems in disseminating modern varieties: example of pigeon pea in semi-arid area of Kenya

    Get PDF
    In the semi-arid Mwea Division of Kenya's Eastern Province, the modern pigeonpea (Cajanus cajan) variety Nairobi Pigeonpea 670 (NPP 670) had become known to all farmers and was being grown by 68% of them within a period of 12 years. The only injection of this seed to the area was from a single on-farm demonstration. Three-quarters of farmers found out about the variety from observing it growing in the field, and obtained seed primarily from other farmers in the village. Factors favouring the diffusion of the variety included its attractiveness as a cash crop, the ease with which it could be distinguished from other varieties, the low seed rate, and the relative ease with which growers were able to maintain seed purity. Farmers expressed a willingness to pay for fresh seed, which suggests that more effort needs to be made to involve the formal seed sector. The present regulatory system does not favour the development of a formal supply system. NPP 670 was released more than 10 years after it was first teste

    Genomic Profiling of Smoldering Multiple Myeloma Identifies Patients at a High Risk of Disease Progression

    Get PDF
    PURPOSE: Smoldering multiple myeloma (SMM) is a precursor condition of multiple myeloma (MM) with a 10% annual risk of progression. Various prognostic models exist for risk stratification; however, those are based on solely clinical metrics. The discovery of genomic alterations that underlie disease progression to MM could improve current risk models. METHODS: We used next-generation sequencing to study 214 patients with SMM. We performed whole-exome sequencing on 166 tumors, including 5 with serial samples, and deep targeted sequencing on 48 tumors. RESULTS: We observed that most of the genetic alterations necessary for progression have already been acquired by the diagnosis of SMM. Particularly, we found that alterations of the mitogen-activated protein kinase pathway (KRAS and NRAS single nucleotide variants [SNVs]), the DNA repair pathway (deletion 17p, TP53, and ATM SNVs), and MYC (translocations or copy number variations) were all independent risk factors of progression after accounting for clinical risk staging. We validated these findings in an external SMM cohort by showing that patients who have any of these three features have a higher risk of progressing to MM. Moreover, APOBEC associated mutations were enriched in patients who progressed and were associated with a shorter time to progression in our cohort. CONCLUSION: SMM is a genetically mature entity whereby most driver genetic alterations have already occurred, which suggests the existence of a right-skewed model of genetic evolution from monoclonal gammopathy of undetermined significance to MM. We identified and externally validated genomic predictors of progression that could distinguish patients at high risk of progression to MM and, thus, improve on the precision of current clinical models

    Personalised progression prediction in patients with monoclonal gammopathy of undetermined significance or smouldering multiple myeloma (PANGEA): a retrospective, multicohort study

    Get PDF
    BACKGROUND: Patients with precursors to multiple myeloma are dichotomised as having monoclonal gammopathy of undetermined significance or smouldering multiple myeloma on the basis of monoclonal protein concentrations or bone marrow plasma cell percentage. Current risk stratifications use laboratory measurements at diagnosis and do not incorporate time-varying biomarkers. Our goal was to develop a monoclonal gammopathy of undetermined significance and smouldering multiple myeloma stratification algorithm that utilised accessible, time-varying biomarkers to model risk of progression to multiple myeloma. METHODS: In this retrospective, multicohort study, we included patients who were 18 years or older with monoclonal gammopathy of undetermined significance or smouldering multiple myeloma. We evaluated several modelling approaches for predicting disease progression to multiple myeloma using a training cohort (with patients at Dana-Farber Cancer Institute, Boston, MA, USA; annotated from Nov, 13, 2019, to April, 13, 2022). We created the PANGEA models, which used data on biomarkers (monoclonal protein concentration, free light chain ratio, age, creatinine concentration, and bone marrow plasma cell percentage) and haemoglobin trajectories from medical records to predict progression from precursor disease to multiple myeloma. The models were validated in two independent validation cohorts from National and Kapodistrian University of Athens (Athens, Greece; from Jan 26, 2020, to Feb 7, 2022; validation cohort 1), University College London (London, UK; from June 9, 2020, to April 10, 2022; validation cohort 1), and Registry of Monoclonal Gammopathies (Czech Republic, Czech Republic; Jan 5, 2004, to March 10, 2022; validation cohort 2). We compared the PANGEA models (with bone marrow [BM] data and without bone marrow [no BM] data) to current criteria (International Myeloma Working Group [IMWG] monoclonal gammopathy of undetermined significance and 20/2/20 smouldering multiple myeloma risk criteria). FINDINGS: We included 6441 patients, 4931 (77%) with monoclonal gammopathy of undetermined significance and 1510 (23%) with smouldering multiple myeloma. 3430 (53%) of 6441 participants were female. The PANGEA model (BM) improved prediction of progression from smouldering multiple myeloma to multiple myeloma compared with the 20/2/20 model, with a C-statistic increase from 0Β·533 (0Β·480-0Β·709) to 0Β·756 (0Β·629-0Β·785) at patient visit 1 to the clinic, 0Β·613 (0Β·504-0Β·704) to 0Β·720 (0Β·592-0Β·775) at visit 2, and 0Β·637 (0Β·386-0Β·841) to 0Β·756 (0Β·547-0Β·830) at visit three in validation cohort 1. The PANGEA model (no BM) improved prediction of smouldering multiple myeloma progression to multiple myeloma compared with the 20/2/20 model with a C-statistic increase from 0Β·534 (0Β·501-0Β·672) to 0Β·692 (0Β·614-0Β·736) at visit 1, 0Β·573 (0Β·518-0Β·647) to 0Β·693 (0Β·605-0Β·734) at visit 2, and 0Β·560 (0Β·497-0Β·645) to 0Β·692 (0Β·570-0Β·708) at visit 3 in validation cohort 1. The PANGEA models improved prediction of monoclonal gammopathy of undetermined significance progression to multiple myeloma compared with the IMWG rolling model at visit 1 in validation cohort 2, with C-statistics increases from 0Β·640 (0Β·518-0Β·718) to 0Β·729 (0Β·643-0Β·941) for the PANGEA model (BM) and 0Β·670 (0Β·523-0Β·729) to 0Β·879 (0Β·586-0Β·938) for the PANGEA model (no BM). INTERPRETATION: Use of the PANGEA models in clinical practice will allow patients with precursor disease to receive more accurate measures of their risk of progression to multiple myeloma, thus prompting for more appropriate treatment strategies. FUNDING: SU2C Dream Team and Cancer Research UK

    TBCRC 030: a phase II study of preoperative cisplatin versus paclitaxel in triple-negative breast cancer: evaluating the homologous recombination deficiency (HRD) biomarker

    Get PDF
    Background: Cisplatin and paclitaxel are active in triple-negative breast cancer (TNBC). Despite different mechanisms of action, effective predictive biomarkers to preferentially inform drug selection have not been identified. The homologous recombination deficiency (HRD) assay (Myriad Genetics, Inc.) detects impaired double-strand DNA break repair and may identify patients with BRCA1/2-proficient tumors that are sensitive to DNA-targeting therapy. The primary objective of TBCRC 030 was to detect an association of HRD with pathologic response [residual cancer burden (RCB)-0/1] to single-agent cisplatin or paclitaxel. Patients and methods: This prospective phase II study enrolled patients with germline BRCA1/2 wild-type/unknown stage I–III TNBC in a 12-week randomized study of preoperative cisplatin or paclitaxel. The HRD assay was carried out on baseline tissue; positive HRD was defined as a score β‰₯33. Crossover to an alternative chemotherapy was offered if there was inadequate response. Results: One hundred and thirty-nine patients were evaluable for response, including 88 (63.3%) who had surgery at 12 weeks and 51 (36.7%) who crossed over to an alternative provider-selected preoperative chemotherapy regimen due to inadequate clinical response. HRD results were available for 104 tumors (74.8%) and 74 (71.1%) were HRD positive. The RCB-0/1 rate was 26.4% with cisplatin and 22.3% with paclitaxel. No significant association was observed between HRD score and RCB response to either cisplatin [odds ratio (OR) for RCB-0/1 if HRD positive 2.22 (95% CI: 0.39–23.68)] or paclitaxel [OR for RCB-0/1 if HRD positive 0.90 (95% CI: 0.19–4.95)]. There was no evidence of an interaction between HRD and pathologic response to chemotherapy. Conclusions: In this prospective preoperative trial in TNBC, HRD was not predictive of pathologic response. Tumors were similarly responsive to preoperative paclitaxel or cisplatin chemotherapy

    ΠœΠ΅ΠΆΠ΄ΡƒΠ½Π°Ρ€ΠΎΠ΄Π½Ρ‹ΠΉ ΠΌΡƒΠ·Ρ‹ΠΊΠ°Π»ΡŒΠ½Ρ‹ΠΉ конкурс Π² Ρ„ΠΎΡ€ΠΌΠΈΡ€ΠΎΠ²Π°Π½ΠΈΠΈ ΠΈΠΌΠΈΠ΄ΠΆΠ° страны провСдСния (Π½Π° ΠΏΡ€ΠΈΠΌΠ΅Ρ€Π΅ ЕвровидСния 2017)

    Get PDF
    Аннотация выпускной ΠΊΠ²Π°Π»ΠΈΡ„ΠΈΠΊΠ°Ρ†ΠΈΠΎΠ½Π½ΠΎΠΉ Ρ€Π°Π±ΠΎΡ‚Ρ‹ ΠžΡ€Π»ΠΎΠ² Никита Π‘Π΅Ρ€Π³Π΅Π΅Π²ΠΈΡ‡ Β«ΠœΠ•Π–Π”Π£ΠΠΠ ΠžΠ”ΠΠ«Π™ ΠœΠ£Π—Π«ΠšΠΠ›Π¬ΠΠ«Π™ КОНКУРБ Π’ Π€ΠžΠ ΠœΠ˜Π ΠžΠ’ΠΠΠ˜Π˜ Π˜ΠœΠ˜Π”Π–Π БВРАНЫ ΠŸΠ ΠžΠ’Π•Π”Π•ΠΠ˜Π― (НА ΠŸΠ Π˜ΠœΠ•Π Π• Π•Π’Π ΠžΠ’Π˜Π”Π•ΠΠ˜Π―-2017)Β» Н. Ρ€ΡƒΠΊ. - Π‘Ρ‹ΠΊΠΎΠ²Π° Π•Π»Π΅Π½Π° Π’Π»Π°Π΄ΠΈΠΌΠΈΡ€ΠΎΠ²Π½Π°, Π΄ΠΎΠΊΡ‚ΠΎΡ€ филологичСских Π½Π°ΡƒΠΊ, Π΄ΠΎΡ†Π΅Π½Ρ‚ ΠšΠ°Ρ„Π΅Π΄Ρ€Π° связСй с ΠΎΠ±Ρ‰Π΅ΡΡ‚Π²Π΅Π½Π½ΠΎΡΡ‚ΡŒΡŽ ΠžΡ‡Π½Π°Ρ Ρ„ΠΎΡ€ΠΌΠ° обучСния ΠΠΊΡ‚ΡƒΠ°Π»ΡŒΠ½ΠΎΡΡ‚ΡŒ: ΠΌΠ΅ΠΆΠ΄ΡƒΠ½Π°Ρ€ΠΎΠ΄Π½Ρ‹ΠΉ ΠΌΡƒΠ·Ρ‹ΠΊΠ°Π»ΡŒΠ½Ρ‹ΠΉ конкурс Π•Π²Ρ€ΠΎΠ²ΠΈΠ΄Π΅Π½ΠΈΠ΅ ΠΊΠ°ΠΊ самоС ΠΌΠ°ΡΡˆΡ‚Π°Π±Π½ΠΎΠ΅ рСгулярноС высокотСхнологичноС Ρ‚Π΅Π»Π΅Π²ΠΈΠ·ΠΈΠΎΠ½Π½ΠΎΠ΅ ΠΈ ΠΌΠ΅Π΄ΠΈΠ°-событиС, ΠΊΠΎΡ‚ΠΎΡ€ΠΎΠ΅ . Π• Π΅ΠΆΠ΅Π³ΠΎΠ΄Π½ΠΎ Π°ΠΊΡ†Π΅Π½Ρ‚ΠΈΡ€ΡƒΠ΅Ρ‚ Π²Π½ΠΈΠΌΠ°Π½ΠΈΠ΅ Π°ΡƒΠ΄ΠΈΡ‚ΠΎΡ€ΠΈΠΈ Π½Π° Π½Π°Ρ†ΠΈΠΎΠ½Π°Π»ΡŒΠ½ΠΎ-ΠΊΡƒΠ»ΡŒΡ‚ΡƒΡ€Π½Ρ‹Ρ… особСнностях страны-ΠΎΡ€Π³Π°Π½ΠΈΠ·Π°Ρ‚ΠΎΡ€Π° конкурса, Ρ„ΠΎΡ€ΠΌΠΈΡ€ΡƒΠ΅Ρ‚ Π·Π½Π°Ρ‡ΠΈΡ‚Π΅Π»ΡŒΠ½Ρ‹Π΅ туристичСскиС ΠΏΠΎΡ‚ΠΎΠΊΠΈ ΠΈ Ρ‚Π΅ΠΌ самым способствуСт Ρ„ΠΎΡ€ΠΌΠΈΡ€ΠΎΠ²Π°Π½ΠΈΡŽ ΠΈΠΌΠΈΠ΄ΠΆΠ° Ρ‚Π΅Ρ€Ρ€ΠΈΡ‚ΠΎΡ€ΠΈΠΈ. Π‘ΠΎΠ»Π΅Π΅ Ρ‚ΠΎΠ³ΠΎ, ΠΏΠΎΠ±Π΅Π΄Π° страны-участницы конкурса ЕвровидСния Π·Π°Ρ‡Π°ΡΡ‚ΡƒΡŽ ΠΎΡ‚Ρ€Π°ΠΆΠ°Π΅Ρ‚ ΠΈΠ΄Π΅ΠΎΠ»ΠΎΠ³ΠΎ-политичСский Π²Π΅ΠΊΡ‚ΠΎΡ€ Π•Π²Ρ€ΠΎΠΏΡ‹ ΠΈ ΠΏΠΎ сути Π΄Π΅Π»Π° выполняСт Ρ„ΡƒΠ½ΠΊΡ†ΠΈΡŽ политичСского PR страны-побСдитСля ΠΈ страны-хозяйки мСроприятия. Π‘Π»Π΅Π΄ΠΎΠ²Π°Ρ‚Π΅Π»ΡŒΠ½ΠΎ Π°Π½Π°Π»ΠΈΠ· ΠΈΡΠΏΠΎΠ»ΡŒΠ·ΡƒΠ΅ΠΌΡ‹Ρ… Π½Π° мСроприятии ΠΊΠΎΠΌΠΌΡƒΠ½ΠΈΠΊΠ°Ρ‚ΠΈΠ²Π½Ρ‹Ρ… Ρ‚Π΅Ρ…Π½ΠΎΠ»ΠΎΠ³ΠΈΠΉ являСтся Π°ΠΊΡ‚ΡƒΠ°Π»ΡŒΠ½Ρ‹ΠΌ ΠΈ вострСбованным для событийного ΠΈ ΡƒΡΡ‚Ρ€ΠΎΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎΠ³ΠΎ PR ΠžΠ±ΡŠΠ΅ΠΊΡ‚ исслСдования: ΠΊΠΎΠΌΠΌΡƒΠ½ΠΈΠΊΠ°Ρ†ΠΈΠΎΠ½Π½Ρ‹Π΅ активности ΠΌΠ΅ΠΆΠ΄ΡƒΠ½Π°Ρ€ΠΎΠ΄Π½ΠΎΠ³ΠΎ ΠΌΡƒΠ·Ρ‹ΠΊΠ°Π»ΡŒΠ½ΠΎΠ³ΠΎ конкурса (Π½Π° ΠΏΡ€ΠΈΠΌΠ΅Ρ€Π΅ ЕвровидСния Π² КиСвС Π² 2017 Π³.). ΠŸΡ€Π΅Π΄ΠΌΠ΅Ρ‚ исслСдования: функция статусного PR-мСроприятия Π² Ρ„ΠΎΡ€ΠΌΠΈΡ€ΠΎΠ²Π°Π½ΠΈΠΈ ΠΈΠΌΠΈΠ΄ΠΆΠ° страны. ЦСль исслСдования: Π΄ΠΎΠΊΠ°Π·Π°Ρ‚ΡŒ, Ρ‡Ρ‚ΠΎ ΠΌΠ΅ΠΆΠ΄ΡƒΠ½Π°Ρ€ΠΎΠ΄Π½Ρ‹ΠΉ ΠΌΡƒΠ·Ρ‹ΠΊΠ°Π»ΡŒΠ½Ρ‹ΠΉ конкурс Π•Π²Ρ€ΠΎΠ²ΠΈΠ΄Π΅Π½ΠΈΠ΅ способствуСт Ρ„ΠΎΡ€ΠΌΠΈΡ€ΠΎΠ²Π°Π½ΠΈΡŽ ΠΈΠΌΠΈΠ΄ΠΆΠ° страны провСдСния. Π—Π°Π΄Π°Ρ‡ΠΈ исслСдования: Ρ€Π°Π·Ρ€Π°Π±ΠΎΡ‚Π°Ρ‚ΡŒ тСрминологичСский Π°ΠΏΠΏΠ°Ρ€Π°Ρ‚ исслСдования Π½Π° основС Π½Π°ΡƒΡ‡Π½ΠΎΠΉ Π»ΠΈΡ‚Π΅Ρ€Π°Ρ‚ΡƒΡ€Ρ‹ ΠΏΠΎ ΠΈΠΌΠΈΠ΄ΠΆΠΌΠ΅ΠΉΠΊΠΈΠ½Π³Ρƒ, Π±Ρ€Π΅Π½Π΄ΠΈΠ½Π³Ρƒ ΠΈ ΠΈΠ²Π΅Π½Ρ‚-ΠΌΠ΅Π½Π΅Π΄ΠΆΠΌΠ΅Π½Ρ‚Ρƒ; ΠΎΠΏΡ€Π΅Π΄Π΅Π»ΠΈΡ‚ΡŒ Π°ΠΊΡ‚ΡƒΠ°Π»ΡŒΠ½Ρ‹Π΅ ΠΊΠΎΠΌΠΌΡƒΠ½ΠΈΠΊΠ°Ρ†ΠΈΠΎΠ½Π½Ρ‹Π΅ Ρ‚Π΅Ρ…Π½ΠΎΠ»ΠΎΠ³ΠΈΠΈ, примСняСмыС Π² Ρ€Π°ΠΌΠΊΠ°Ρ… ΡΠΏΠ΅Ρ†ΠΈΠ°Π»ΡŒΠ½Ρ‹Ρ… событий для формирования ΠΈΠΌΠΈΠ΄ΠΆΠ° страны; ΠΎΠΏΠΈΡΠ°Ρ‚ΡŒ Ρ€ΠΎΠ»ΡŒ ЕвропСйского Π’Π΅Ρ‰Π°Ρ‚Π΅Π»ΡŒΠ½ΠΎΠ³ΠΎ Боюза ΠΊΠ°ΠΊ ΠΎΡ€Π³Π°Π½ΠΈΠ·Π°Ρ‚ΠΎΡ€Π° ЕвровидСния Π² Ρ„ΠΎΡ€ΠΌΠΈΡ€ΠΎΠ²Π°Π½ΠΈΠΈ ΠΈΠΌΠΈΠ΄ΠΆΠ° страны провСдСния конкурса; ΠΎΡ†Π΅Π½ΠΈΡ‚ΡŒ ΡΡ„Ρ„Π΅ΠΊΡ‚ΠΈΠ²Π½ΠΎΡΡ‚ΡŒ Ρ€Π΅Π°Π»ΠΈΠ·ΠΎΠ²Π°Π½Π½Ρ‹Ρ… ΠΊΠΎΠΌΠΌΡƒΠ½ΠΈΠΊΠ°Ρ‚ΠΈΠ²Π½Ρ‹Ρ… Ρ‚Π΅Ρ…Π½ΠΎΠ»ΠΎΠ³ΠΈΠΉ формирования ΠΈΠΌΠΈΠ΄ΠΆΠ° страны Π² Ρ€Π°ΠΌΠΊΠ°Ρ… ЕвровидСния; Π΄Π°Ρ‚ΡŒ Ρ€Π΅ΠΊΠΎΠΌΠ΅Π½Π΄Π°Ρ†ΠΈΠΈ ΠΏΠΎ Ρ„ΠΎΡ€ΠΌΠΈΡ€ΠΎΠ²Π°Π½ΠΈΡŽ ΠΈΠΌΠΈΠ΄ΠΆΠ° страны с ΠΏΠΎΠΌΠΎΡ‰ΡŒΡŽ ЕвровидСния. ВСорСтичСская Π±Π°Π·Π°: Π½Π°ΡƒΡ‡Π½Ρ‹Π΅ Ρ‚Ρ€ΡƒΠ΄Ρ‹ Π•. Π‘Ρ‹ΠΊΠΎΠ²ΠΎΠΉ, Π”. Π“Π°Π²Ρ€Ρ‹, А. ΠŸΠ°Π½ΠΊΡ€ΡƒΡ…ΠΈΠ½Π°, Π‘. ДТСнСса, Π•. ΠšΠ°Π²Π΅Ρ€ΠΈΠ½ΠΎΠΉ, Π£. Π₯Π°Π»ΡŒΡ†Π±Π°ΡƒΡ€Π°, Π”ΠΆ. Π“ΠΎΠ»Π΄Π±Π»Π°Ρ‚Ρ‚Π° Π° Ρ‚Π°ΠΊΠΆΠ΅ Ρ‚Ρ€ΡƒΠ΄Ρ‹ Π”. Пассмана ΠΎ ΠΌΡƒΠ·Ρ‹ΠΊΠ°Π»ΡŒΠ½ΠΎΠΌ бизнСсС, П. Π”ΠΆΠΎΡ€Π΄Π°Π½Π° ΠΎ ΠΏΡ€ΠΎΠ΄Π²ΠΈΠΆΠ΅Π½ΠΈΠΈ ΠΈΠΌΠΈΠ΄ΠΆΠ° стран с ΠΏΠΎΠΌΠΎΡ‰ΡŒΡŽ ЕвровидСния ΠΈ Π΄Ρ€. ЭмпиричСская Π±Π°Π·Π°: PR-Π΄ΠΎΠΊΡƒΠΌΠ΅Π½Ρ‚Ρ‹, Ρ€Π°Π·ΠΌΠ΅Ρ‰Π΅Π½Π½Ρ‹Π΅ Π½Π° сайтС ЕвровидСния ΠΈ ЕвропСйского Π’Π΅Ρ‰Π°Ρ‚Π΅Π»ΡŒΠ½ΠΎΠ³ΠΎ Боюза; Π±ΠΎΠ»Π΅Π΅ ΠΏΠΎΠ»ΡƒΡ‚ΠΎΡ€Π° ΠΌΠΈΠ»Π»ΠΈΠΎΠ½Π° статСй ΠΎΠ± Π£ΠΊΡ€Π°ΠΈΠ½Π΅ Π² СвропСйских БМИ, Ρ€Π°Π·ΠΌΠ΅Ρ‰Π΅Π½Π½Ρ‹Π΅ Π² Π±Π°Π·Π΅ ΠΏΡ€ΠΎΠ΅ΠΊΡ‚Π° ΠΌΠΎΠ½ΠΈΡ‚ΠΎΡ€ΠΈΠ½Π³Π° ΠΌΠ΅ΠΆΠ΄ΡƒΠ½Π°Ρ€ΠΎΠ΄Π½ΠΎΠ³ΠΎ ΠΈΠΌΠΈΠ΄ΠΆΠ° Π£ΠΊΡ€Π°ΠΈΠ½Ρ‹ Β«OkoΒ»; Π΄Π°Π½Π½Ρ‹Π΅ Π±Π°Π·Ρ‹ ΠΌΠ°Ρ‚Π΅Ρ€ΠΈΠ°Π»ΠΎΠ² БМИ ΠΈ ΡΠΎΡ†ΠΈΠ°Π»ΡŒΠ½Ρ‹Ρ… ΠΌΠ΅Π΄ΠΈΠ° Factiva; Π΄Π°Π½Π½Ρ‹Π΅ Google.Analytics. ΠŸΡ€Π°ΠΊΡ‚ΠΈΡ‡Π΅ΡΠΊΠ°Ρ Π·Π½Π°Ρ‡ΠΈΠΌΠΎΡΡ‚ΡŒ: исслСдованиС Π΄ΠΎΠΊΠ°Π·Ρ‹Π²Π°Π΅Ρ‚, Ρ‡Ρ‚ΠΎ ΠΌΠ΅ΠΆΠ΄ΡƒΠ½Π°Ρ€ΠΎΠ΄Π½Ρ‹ΠΉ ΠΌΡƒΠ·Ρ‹ΠΊΠ°Π»ΡŒΠ½Ρ‹ΠΉ конкурс Π•Π²Ρ€ΠΎΠ²ΠΈΠ΄Π΅Π½ΠΈΠ΅ Ρ„ΠΎΡ€ΠΌΠΈΡ€ΡƒΠ΅Ρ‚ ΠΈΠΌΠΈΠ΄ΠΆ страны провСдСния нСзависимо ΠΎΡ‚ ΡƒΡΠΏΠ΅ΡˆΠ½ΠΎΡΡ‚ΠΈ использования ΠΊΠΎΠ½ΠΊΡ€Π΅Ρ‚Π½Ρ‹Ρ… Ρ‚Π΅Ρ…Π½ΠΎΠ»ΠΎΠ³ΠΈΠΉ формирования ΠΈΠΌΠΈΠ΄ΠΆΠ° страны. ВСзисы исслСдования Π±Ρ‹Π»ΠΈ Π°ΠΏΡ€ΠΎΠ±ΠΈΡ€ΠΎΠ²Π°Π½Ρ‹ Π½Π° ΠΌΠ΅ΠΆΠ΄ΡƒΠ½Π°Ρ€ΠΎΠ΄Π½ΠΎΠΌ Π½Π°ΡƒΡ‡Π½ΠΎΠΌ Ρ„ΠΎΡ€ΡƒΠΌΠ΅ «МСдиа Π² соврСмСнном ΠΌΠΈΡ€Π΅. 57-Π΅ ΠŸΠ΅Ρ‚Π΅Ρ€Π±ΡƒΡ€Π³ΡΠΊΠΈΠ΅ чтСния», ΠΎΠΏΡƒΠ±Π»ΠΈΠΊΠΎΠ²Π°Π½Ρ‹ Π² сборникС ΠΌΠ°Ρ‚Π΅Ρ€ΠΈΠ°Π»ΠΎΠ² статСй Ρ„ΠΎΡ€ΡƒΠΌΠ° ΠΈ ΠΈΠΌΠ΅ΡŽΡ‚ статус Π½Π°ΡƒΡ‡Π½ΠΎΠΉ ΡΡ‚Π°Ρ‚ΡŒΠΈ, Ρ€Π°Π·ΠΌΠ΅Ρ‰Π΅Π½Π½ΠΎΠΉ Π² Π±Π°Π·Π΅ РИНЦ. Π‘Ρ‚Ρ€ΡƒΠΊΡ‚ΡƒΡ€Π° Ρ€Π°Π±ΠΎΡ‚Ρ‹: Π Π°Π±ΠΎΡ‚Π° состоит ΠΈΠ· ввСдСния, 3 Π³Π»Π°Π²: «функция ΡΠΏΠ΅Ρ†ΠΈΠ°Π»ΡŒΠ½ΠΎΠ³ΠΎ события Π² Ρ„ΠΎΡ€ΠΌΠΈΡ€ΠΎΠ²Π°Π½ΠΈΠΈ ΠΈΠΌΠΈΠ΄ΠΆΠ° страны», Β«Π•Π²Ρ€ΠΎΠ²ΠΈΠ΄Π΅Π½ΠΈΠ΅ ΠΊΠ°ΠΊ ΡΠΏΠ΅Ρ†ΠΈΠ°Π»ΡŒΠ½ΠΎΠ΅ событиС ЕвропСйского Π’Π΅Ρ‰Π°Ρ‚Π΅Π»ΡŒΠ½ΠΎΠ³ΠΎ Боюза» ΠΈ Β«ΠΊΠΎΠΌΠΌΡƒΠ½ΠΈΠΊΠ°Ρ†ΠΈΠΎΠ½Π½Ρ‹ΠΉ ΠΏΠΎΡ‚Π΅Π½Ρ†ΠΈΠ°Π» ЕвровидСния ΠΊΠ°ΠΊ ΠΏΠ»ΠΎΡ‰Π°Π΄ΠΊΠΈ для формирования ΠΈΠΌΠΈΠ΄ΠΆΠ° страны», Π·Π°ΠΊΠ»ΡŽΡ‡Π΅Π½ΠΈΡ, списка использованной Π»ΠΈΡ‚Π΅Ρ€Π°Ρ‚ΡƒΡ€Ρ‹ ΠΈΠ· 67 ΠΏΠΎΠ·ΠΈΡ†ΠΈΠΉ ΠΈ 12 ΠΏΡ€ΠΈΠ»ΠΎΠΆΠ΅Π½ΠΈΠΉ. ΠžΠ±Ρ‰ΠΈΠΉ объСм 76 страниц.Abstract of graduating qualification thesis Mikita Arlou INTERNATIONAL MUSIC CONTEST IN HOST COUNTRY IMAGE FORMATION (ON THE EXAMPLE OF EUROVISION 2017) Supervisor associate professor Elena Bykova, doctor of philology Department of PR in business full-time study Relevance: the international music contest Eurovision as the most wide scale regular high tech TV and Media event which annually emphasizes audience attention on national cultural features of the host country, forms tourist flows which have huge influence on territorial image formation. Besides the win of a participating in the Eurovision country often shows the ideological and political European vector and in fact serves as political PR of the winning or host country. Consequently the analysis of applied communication technologies is relevant and in-demand for event PR. Research object: communication activities of international music contest (on the example of Eurovision in Kyiv in 2017). Research subject: function of status PR event in country image formation. The aim of research: to prove that international music contest Eurovision contributes host country image formation. The tasks of research: to develop research terminology based on scientific literature on image making, branding and event management; to define actual communication technologies applied in special PR events on country image formation; to describe European Broadcasting Union role in host country image formation; to appreciate effectiveness of applied communication technologies on host country image formation in Eurovision; to give recommendations for host country image formation with the help of Eurovision. Theoretical base: scientific works written by E. Bykova, D. Gavra, A. Pankrukhin, B. Jenes, E. Kaverina, U. Halcbaur, J. Goldblatt and D. PassmanΒ΄s works on music business and P. Jordan on county image building with the help of Eurovision, etc. The empirical base: PR documents from official Eurovision and European Broadcasting Union websites; more than 1.5 million articles on Ukraine in European media stored in the base of international Ukrainian image monitoring project Oko; content of the mass media and social media base Factiva; Google.Analytics data. Practical significance: the research proves that international music contest Eurovision is relevant for the host country image formation independently of the success level of applied country image formation communication technologies. Approbation: General positions of current thesis were aprobated on international scientific forum Media in modern world and were published at the collection of articles of the forum and have the status of a scientific article posted in the RINC database. Thesis structure: Research consists of introduction, 3 chapters: Special event function in country image formation, Eurovision as EBU special event and communication potential of Eurovision as a platform for image formation; conclusion, literature list from 67 positions and 12 attachments. The total volume is 76 pages
    • …
    corecore